Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.5.3151

Lack of Relationships between FGF19 Staining Pattern, Lymph Node Metastasis and Locally Invasive Characteristics of the Tumor in Colorectal Cancers  

Unal, Hakan Umit (Gastroenterology Department, Baskent University Faculty of Medicine)
Demiralay, Ebru (Pathology Department, Baskent University Faculty of Medicine)
Tepeoglu, Merih (Pathology Department, Baskent University Faculty of Medicine)
Fidan, Cihan (Family Medicine, Baskent University Faculty of Medicine)
Kilickap, Saadettin (Preventive Oncology, Hacettepe University Cancer Institute)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.5, 2013 , pp. 3151-3154 More about this Journal
Abstract
Introduction: Colorectal cancers are in the top of the cancer-related causes of death in the world and lymph node metastasis is accepted as the primary prognostic factor. In this study, correlations of FGF19 staining pattern with local invasion and lymph node metastasis in a series of colorectal cancers were investigated. Methods: This studyincluded 81 colorectal cancer patients who underwent surgery in our hospital with no evidence of preoperative radiological distant metastasis. Routine pathological examination of the resection material was performed in order to identify vascular, perineural and serosal infiltration, regional lymph node metastasis and the degree of differentiation. Tumor tissue samples were stained with an immunohistochemistry method for FGF 19 evaluation and the staining pattern was statistically compared with the above mentioned characteristics of the tumors. Results: The patient population consisted of 47 females and 34 males with a median age of 70 years. In 40 patients regional lymph nodes were positive and 51%, 32% and 38% had serosal, perineural and vascular invasion. While 64 cases were moderately-differentiated, 11 cases were well-differentiated and 6 poorlydifferentiated, there was no association with FGF 19 staining, including intensity. Conclusion: No evidence of significant statistically correlation was found between FGF 19 staining pattern and serosal, perineural, vascular invasion, lymph node involvement and degree of differentiation.
Keywords
Colorectal cancer; FGF staining; lymph node metastasis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ainsworth PD, Johnson MA (2010). The prognostic significance of the metastatic lymph node ratio in Dukes stage C colorectal cancer in a district general hospital. Colorectal Dis, 12, 1219-22.   DOI   ScienceOn
2 Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000). American joint committee on cancer prognostic factors consensus conference: colorectal working group. Cancer, 88, 1739-57.   DOI   ScienceOn
3 Desnoyers LR, Pai R, Ferrando RE, et al (2008). Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene, 27, 85-97.   DOI   ScienceOn
4 Engstrom W, Granerus M (2006). Effects of fibroblast growth factors 19 and 20 on cell multiplication and locomotion in a human embryonal carcinoma cell line (Tera-2) in vitro. Anticancer Res, 26, 3307-10.
5 Feng S, Dakhova O, Creighton CJ, Ittmann M (2013). Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression. Cancer Res, 73, 2551-62.   DOI   ScienceOn
6 French DM, Lin BC, Wang M, et al (2012). Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One, 7, 36713.   DOI
7 Gout S, Huot J (2008). Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 1, 69-83.   DOI
8 Hyeon J, Ahn S, Lee JJ, Song DH, Park CK (2013). Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma. Dig Dis Sci, [Epub ahead of print].
9 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
10 Johnson PM, Porter GA, Ricciardi R, Baxter NN (2006). Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol, 24, 3570-5.   DOI   ScienceOn
11 Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A (2011). Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology, 43, 133-7.   DOI   ScienceOn
12 Katoh M (2006). Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther, 5, 1059-64.   DOI
13 Ornitz DM (2005). FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev, 16, 205-13.   DOI   ScienceOn
14 Lin BC, Desnoyers LR (2012). FGF19 and cancer. Adv Exp Med Biol, 728, 183-94.   DOI
15 Miyake A, Nakayama Y, Konishi M, Itoh N (2005). Fgf19 regulated by Hh signaling is required for zebrafish forebrain development. Dev Biol, 288, 259-75.   DOI   ScienceOn
16 Nicholes K, Guillet S, Tomlinson E, et al (2002). A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol, 160, 2295-307.   DOI   ScienceOn
17 Pai R, Dunlap D, Qing J, et al (2008). Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating betacatenin signaling. Cancer Res, 68, 5086-95.   DOI   ScienceOn
18 Quirke P, Williams GT, Ectors N, et al (2007). The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol, 8, 651-7.   DOI   ScienceOn
19 Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg, 248, 968-78.   DOI   ScienceOn
20 Royston D, Jackson DG (2009). Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol, 217, 608-19.   DOI   ScienceOn
21 Siffroi-Fernandez S, Felder-Schmittbuhl MP, Khanna H, Swaroop A, Hicks D (2008). FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro. Invest Ophthalmol Vis Sci, 49, 1696-704.   DOI   ScienceOn
22 Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008). Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol, 15, 1600-8.   DOI   ScienceOn
23 Xie MH, Holcomb I, Deuel B, et al (1999). FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine, 11, 729-35.   DOI   ScienceOn
24 Wu X, Ge H, Lemon B, et al (2010). FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem, 285, 5165-70.   DOI   ScienceOn